Immunopharmacology and Immunotoxicology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 54.5% | 0.723 | Q2 | 73.9% |
| 2024 | 3.0 | Q2 | 61.2% | 0.725 | Q2 | 74.7% |
| 2023 | 2.9 | Q2 | 55.3% | 0.680 | Q2 | 74.8% |
| 2022 | 3.3 | Q2 | 64.3% | 0.594 | Q2 | 71.7% |
| 2021 | 3.7 | Q2 | 62.9% | 0.631 | Q2 | 74.4% |
| 2020 | — | — | 0.701 | Q2 | 76.2% | |
| 2019 | — | — | 0.635 | Q2 | 74.3% | |
| 2018 | — | — | 0.585 | Q2 | 70.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0892-3973
ISSN
1532-2513
country
GBcoverage
1978-2026